Mosaic ImmunoEngineering Inc. (CPMV)
OTCMKTS: CPMV · Delayed Price · USD
0.598
+0.048 (8.73%)
Jul 2, 2024, 11:15 AM EDT - Market closed
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $4.33 million as of July 2, 2024. Its market cap has decreased by -25.19% in one year.
Market Cap
4.33M
Enterprise Value
5.38M
1-Year Change
-25.19%
Ranking
n/a
Category
Stock Price
$0.60
Market Cap Chart
Since July 3, 2019, Mosaic ImmunoEngineering's market cap has increased from $1.32M to $4.33M, an increase of 229.29%. That is a compound annual growth rate of 26.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 4.33M | -0.33% |
| Dec 29, 2023 | 4.34M | -39.39% |
| Dec 30, 2022 | 7.16M | -2.94% |
| Dec 31, 2021 | 7.38M | -56.53% |
| Dec 31, 2020 | 16.98M | 2,562.66% |
| Dec 31, 2019 | 637.68K | -51.52% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |